
Peking University First Hospital has a total capacity of 1,805 beds across three campuses: Central, Miyun, and Daxing. The hospital delivers a full range of inpatient and outpatient services, serving patients across China and internationally.
Established in 1915, Peking University First Hospital (PUFH) is one of China's most prestigious medical institutions, affiliated with the Peking University Health Science Center. As a top-tier tertiary hospital classified as Grade 3A, it is recognized for its leadership in clinical excellence, education, and research. Over the decades, PUFH has been pioneering in shaping modern Chinese medicine, particularly in specialties such as urology, nephrology, pediatrics, neurology, cardiology, and organ transplantation.
The hospital is home to a team of highly qualified doctors and professors, including many national-level experts. Known for managing complex and rare diseases, it continues to advance patient care through innovation, multidisciplinary collaboration, and compassionate treatment.
Advanced Technology & Facilities
Key Services at Peking University First Hospital
Peking University First Hospital blends a century of medical heritage with high-quality clinical care, innovative research, and comprehensive education. It stands as a benchmark of excellence in China, committed to improving patient outcomes through multidisciplinary collaboration and compassionate, personalized care.

The hospital has approximately 50 inpatient beds in its main campus, along with nine satellite clinics across Beijing. It manages over 2,500 outpatient visits each week and provides care to hundreds of thousands of patients annually, both local and international.
Beijing United Family Hospital (BJU) is one of China’s most prestigious private medical institutions, known for delivering world-class healthcare that meets international standards. Established in 1997, it was the first foreign-invested hospital in China and has since become a trusted choice for both International and Chinese patients seeking high-quality, patient-focused care. As part of the United Family Healthcare network, BJU has built a reputation for medical excellence, advanced technology, and a uniquely personalized approach to treatment.
The hospital is staffed by a diverse team of internationally trained doctors, many of whom have practiced in top healthcare systems across the U.S., Europe, and Asia. This global expertise is complemented by the latest medical equipment, multilingual support services, and a strong commitment to clinical safety and patient satisfaction. Recognized by the Joint Commission International (JCI) for meeting the highest standards in healthcare delivery, BJU offers a full spectrum of medical services across numerous specialties, including family medicine, internal medicine, orthopedics, oncology, cardiology, obstetrics, pediatrics, and plastic surgery.
Advanced Technology & Facilities
Key Services at BJU
Beijing United Family Hospital stands as a pioneer in international-standard healthcare in China, blending modern technology, world-class medical expertise, and a warm, comprehensive approach to family health.

As part of Singapore‑listed Raffles Medical Group, founded in 1976, RMG China operates 5 tertiary hospitals and over 100 clinics, supported by 430+ physicians and 900+ nurses & allied health professionals, delivering comprehensive inpatient and outpatient services.
Raffles Medical Group has operated in China since 2010, growing into a trusted name among both local and expatriate communities. All RMG China hospitals and clinics follow the Group’s Institutional Group Practice Model, which emphasizes integrated, peer-reviewed, and clinically audited care. Backed by Raffles Hospital Singapore, accredited by Joint Commission International (JCI), the network ensures alignment with global standards for quality and patient safety. With a rigorous clinical governance framework, strategic insurance and corporate partnerships, and a presence in key Chinese cities, RMG serves over 2.8 million patients annually. The Group continues to expand across China, offering world-class healthcare that combines international expertise with localized, patient-centered care.
Advanced Technology & Facilities
Key Services at Raffles Medical Group China
Raffles Medical Group China is a leading integrated private hospital network, delivering high-quality, multidisciplinary medical care in major Chinese cities. With its robust institutional infrastructure, advanced diagnostic and treatment facilities, and a reputation anchored by the Singapore-based Raffles Hospital, RMG China continues to expand and uphold global healthcare standards.

GoBroad Healthcare Group, founded in 2017, is a leading medical network in China, specializing in the treatment of complex hematologic diseases and solid tumors. The group integrates clinical treatment, research, reference laboratories, and medical information technology under an Academic Research Organization model. With seven hospitals across Beijing, Shanghai, and Guangzhou, it provides advanced therapies including CAR-T cell therapy, hematopoietic stem cell transplantation, chemotherapy, radiotherapy, and targeted therapy. Its multidisciplinary teams ensure that patients receive comprehensive and personalized treatment for both common and rare conditions. The group is known for its patient-centered approach by combining modern medical science with innovative therapies and long-term follow-up care. With international collaborations, multilingual staff, and dedicated global patient services, it has become a trusted choice for individuals seeking specialized cancer and hematology treatments in China. By focusing on research-driven medicine, advanced facilities, and supportive care, GoBroad Healthcare Group continues to enhance patient survival, recovery, and long-term quality of life.
Advanced Technology & Facilities
Key Services



Beijing has become a trusted center for bone marrow transplant because its hospitals combine experienced hematology teams with advanced transplant units that meet strict accreditation and safety standards. Many centers follow structured protocols for donor matching, infection control, and post transplant monitoring, helping patients feel supported throughout each stage of care. Treatment costs typically range from USD 65000 to USD 120000, depending on factors such as transplant type, length of hospitalization, and the patient's overall medical condition. Most patients resume light daily activity within four to six weeks, though this varies by individual recovery speed and post transplant health.
Clinics in Beijing also provide detailed preoperative evaluations, including imaging and laboratory testing, so transplant teams can determine whether a patient is an ideal candidate. Not every patient qualifies for this procedure, so each case requires individual assessment and a tailored treatment plan by the clinic team. A common patient question is how long they need to remain in Beijing after transplant. Most clinics advise an extended stay for close monitoring, but the exact timeframe is determined during medical evaluation.
This information is for educational purposes and does not replace an in person consultation with a qualified specialist.
Beijing clinics known for bone marrow transplant care maintain organized systems that guide patients from diagnosis through post transplant follow up. Facilities are typically clean, well equipped, and supported by teams trained in managing complex blood cancers. Many centers also provide language assistance and care coordinators for international patients, helping them navigate each phase of the transplant process with clarity.
Care in Beijing often begins with comprehensive assessment that may include bone marrow biopsy, high resolution imaging, and donor search planning. Treatment pathways usually involve structured safety checks, anesthesia planning when required, and continuous infection control. Clinics emphasize transparency about common risks such as graft versus host disease and explain how these are monitored and managed. A frequent patient question is whether clinics can help with donor coordination, and most major centers do support both related and unrelated donor pathways.
Among the leading options are Peking University Peoples Hospital, Lu Daopei Hospital, and Beijing GoBroad Boren Hospital. Peking University Peoples Hospital is widely known for its high volume transplant program and the Beijing Protocol, which expands donor availability for patients who lack a fully matched donor. The hospital combines advanced diagnostic capabilities with a large hematology team that provides structured postoperative monitoring.
Lu Daopei Hospital focuses on leukemia, lymphoma, and stem cell transplantation, offering modern transplant units and close patient follow up. The hospital is recognized for its clinical outcomes and its ability to support patients with high risk or relapsed disease. Beijing GoBroad Boren Hospital offers newer, research active transplant services with a focus on cellular immunotherapies and salvage transplant strategies. Its international support services and transparent care pathways help patients understand their treatment timeline and safety steps.
Best Clinic Abroad supports international patients who are considering bone marrow transplant in Beijing. The team helps connect you with vetted clinics, clarify your options, and coordinate key details around your treatment stay.
➤ Initial virtual consultation - Arrange an online discussion with shortlisted clinics so doctors can provide preliminary feedback.
➤ Clear package information - Receive transparent quotes that outline typical inclusions such as hospital stay, transplant related services, and follow up appointments.
If you are exploring bone marrow transplant in Beijing, you can begin by sharing your case with Best Clinic Abroad and receive guided support to choose a suitable clinic and plan your next steps.